Cargando…
Enrichment of apolipoprotein A-IV and apolipoprotein D in the HDL proteome is associated with HDL functions in diabetic kidney disease without dialysis
BACKGROUND AND AIMS: Diabetic kidney disease (DKD) is associated with lipid derangements that worsen kidney function and enhance cardiovascular (CVD) risk. The management of dyslipidemia, hypertension and other traditional risk factors does not completely prevent CVD complications, bringing up the p...
Autores principales: | Santana, Monique F. M., Lira, Aécio L. A., Pinto, Raphael S., Minanni, Carlos A., Silva, Amanda R. M., Sawada, Maria I. B. A. C., Nakandakare, Edna R., Correa-Giannella, Maria L. C., Queiroz, Marcia S., Ronsein, Graziella E., Passarelli, Marisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488728/ https://www.ncbi.nlm.nih.gov/pubmed/32921312 http://dx.doi.org/10.1186/s12944-020-01381-w |
Ejemplares similares
-
Circulating HDL and Non-HDL Associated Apolipoproteins and Breast Cancer Severity
por: Bobin-Dubigeon, Christine, et al.
Publicado: (2022) -
Apolipoprotein A-I modulates HDL particle size in the absence of apolipoprotein A-II
por: Melchior, John T., et al.
Publicado: (2021) -
Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol
por: Contois, John H., et al.
Publicado: (2023) -
Persistent Effect of Advanced Glycated Albumin Driving Inflammation and Disturbances in Cholesterol Efflux in Macrophages
por: Minanni, Carlos André, et al.
Publicado: (2021) -
Dalcetrapib and anacetrapib increase apolipoprotein E-containing HDL in rabbits and humans
por: Brodeur, Mathieu R., et al.
Publicado: (2022)